# PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.

> **NCT03502824** · NA · TERMINATED · sponsor: **Organogenesis** · enrollment: 40 (actual)

## Conditions studied

- Chronic Pressure Ulcers

## Interventions

- **DEVICE:** PuraPly® Antimicrobial Wound Matrix
- **OTHER:** SOC for Pressure Ulcers

## Key facts

- **NCT ID:** NCT03502824
- **Lead sponsor:** Organogenesis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-01
- **Primary completion:** 2021-09-15
- **Final completion:** 2021-09-15
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** slow enrollment
- **Last updated:** 2021-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03502824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03502824, "PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03502824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*